Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.

Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, Ford JM, Desser T, Quon A, Koong AC.

Cancer. 2009 Feb 1;115(3):665-72. doi: 10.1002/cncr.24059.

2.

Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins.

Rwigema JC, Heron DE, Parikh SD, Zeh HJ 3rd, Moser JA, Bahary N, Ashby K, Burton SA.

J Gastrointest Cancer. 2012 Mar;43(1):70-6. doi: 10.1007/s12029-010-9203-7.

PMID:
20809393
3.

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.

Tozzi A, Comito T, Alongi F, Navarria P, Iftode C, Mancosu P, Reggiori G, Clerici E, Rimassa L, Zerbi A, Fogliata A, Cozzi L, Tomatis S, Scorsetti M.

Radiat Oncol. 2013 Jun 21;8:148. doi: 10.1186/1748-717X-8-148.

4.

Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated.

Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):516-22. doi: 10.1016/j.ijrobp.2013.02.022.

PMID:
23562768
5.

Management of nonsinonasal neuroendocrine carcinomas of the head and neck.

Barker JL Jr, Glisson BS, Garden AS, El-Naggar AK, Morrison WH, Ang KK, Chao KS, Clayman G, Rosenthal DI.

Cancer. 2003 Dec 1;98(11):2322-8.

6.

Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.

Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y, Ozhasoglu C, Burton S.

Am J Clin Oncol. 2010 Jun;33(3):286-93. doi: 10.1097/COC.0b013e3181aacba5.

PMID:
19875950
7.

Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas.

Wong AA, Delclos ME, Wolff RA, Evans DB, Abbruzzese JL, Tamm EP, Xiong HQ, Ho L, Crane CH; Pancreatic Tumor Study Group..

Am J Clin Oncol. 2005 Jun;28(3):227-33.

PMID:
15923793
8.

Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.

Salazar OM, Sandhu TS, Lattin PB, Chang JH, Lee CK, Groshko GA, Lattin CJ.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):707-15. doi: 10.1016/j.ijrobp.2008.01.054.

PMID:
18455322
9.

Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma.

Ceha HM, van Tienhoven G, Gouma DJ, Veenhof CH, Schneider CJ, Rauws EA, Phoa SS, González González D.

Cancer. 2000 Dec 1;89(11):2222-9.

PMID:
11147592
10.

Stereotactic Body Radiation Therapy (SBRT) for lung metastases.

Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, Schell MC.

Acta Oncol. 2006;45(7):808-17.

PMID:
16982544
11.

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.

Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, Johansson KA, Ekberg L, Morhed E, Paludan M, Wittgren L, Blomgren H, Lewensohn R.

Acta Oncol. 2006;45(7):787-95.

PMID:
16982541
12.

Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer.

Mahadevan A, Miksad R, Goldstein M, Sullivan R, Bullock A, Buchbinder E, Pleskow D, Sawhney M, Kent T, Vollmer C, Callery M.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e615-22. doi: 10.1016/j.ijrobp.2011.04.045.

PMID:
21658854
13.

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

Herman JM, Chang DT, Goodman KA, Dholakia AS, Raman SP, Hacker-Prietz A, Iacobuzio-Donahue CA, Griffith ME, Pawlik TM, Pai JS, O'Reilly E, Fisher GA, Wild AT, Rosati LM, Zheng L, Wolfgang CL, Laheru DA, Columbo LA, Sugar EA, Koong AC.

Cancer. 2015 Apr 1;121(7):1128-37. doi: 10.1002/cncr.29161.

14.

Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer.

Schellenberg D, Kim J, Christman-Skieller C, Chun CL, Columbo LA, Ford JM, Fisher GA, Kunz PL, Van Dam J, Quon A, Desser TS, Norton J, Hsu A, Maxim PG, Xing L, Goodman KA, Chang DT, Koong AC.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):181-8. doi: 10.1016/j.ijrobp.2010.05.006.

PMID:
21549517
15.

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.

Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE.

J Clin Oncol. 2009 Apr 1;27(10):1572-8. doi: 10.1200/JCO.2008.19.6329.

PMID:
19255321
16.

Stereotactic body radiation therapy boost in locally advanced pancreatic cancer.

Seo Y, Kim MS, Yoo S, Cho C, Yang K, Yoo H, Choi C, Lee D, Kim J, Kim MS, Kang H, Kim Y.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1456-61. doi: 10.1016/j.ijrobp.2009.01.042.

PMID:
19783379
17.

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R.

J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681.

PMID:
19414667
18.

Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.

Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):486-93. doi: 10.1016/j.ijrobp.2009.08.020.

PMID:
20350791
19.

Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, Sherman M, Dawson LA.

J Clin Oncol. 2008 Feb 1;26(4):657-64. doi: 10.1200/JCO.2007.14.3529. Erratum in: J Clin Oncol. 2008 Aug 10;26(23):3911-2.

PMID:
18172187
20.

Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors.

Barney BM, Olivier KR, Macdonald OK, Fong de Los Santos LE, Miller RC, Haddock MG.

Am J Clin Oncol. 2012 Dec;35(6):537-42. doi: 10.1097/COC.0b013e31821f876a.

PMID:
21659830
Items per page

Supplemental Content

Support Center